Biofrontera Inc. (BFRI) News
Follow Biofrontera Inc. (BFRI) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Biofrontera reports results for the first half of 2026
Biofrontera AGby Investor RelationsBusiness news for the stock marketBiofrontera AG: Biofrontera reports results for the first half of 2026Leverkusen (pta000/30.09.2026/13:30 UTC+2)Leverkusen, September 30, 2026 — Biofro
EQUITY | Sep 30, 2026, 11:31 AM UTC
L
PTA-News: Biofrontera AG: Biofrontera reports results for the first half of 2026
Biofrontera AGby Investor RelationsBusiness news for the stock market Leverkusen (pta/30.09.2026/13:30) - Leverkusen, September 30, 2026 — Biofrontera AG (ISIN: DE000A4BGGM7), an international biopharmaceutical company s
EARNINGS | Sep 30, 2026, 11:31 AM UTC
L
Pre-announcement of a financial report according to articles 114 - 117 WpHG
Biofrontera AGby Investor RelationsPre-announcement of a financial report according to articles 114 - 117 WpHGBiofrontera AG: Pre-announcement of a financial report according to articles 114 - 117 WpHGLeverkusen (pta000/
NEWS | Sep 30, 2026, 10:45 AM UTC
L
PTA-AFR: Biofrontera AG: Pre-announcement of a financial report according to articles 114 - 117 WpHG
Biofrontera AGby Investor RelationsPre-announcement of a financial report according to articles 114 - 117 WpHG Leverkusen (pta/30.09.2026/12:45) - Biofrontera AG announces that the following financial reports shall be di
NEWS | Sep 30, 2026, 10:45 AM UTC
H
Transcript: Biofrontera Q2 2026 Earnings Conference Call
On Thursday, Biofrontera (NASDAQ: BFRI ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and tran
LIVE | Sep 28, 2026, 12:47 PM UTC
M
Biofrontera receives FDA approval for Ameluz with RhodoLED
Biofrontera (BFRI) said it has received FDA approval for Ameluz when used in combination with the RhodoLED.
REGULATION | Sep 10, 2026, 03:31 PM UTC